Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (571-580 of 594) with videos related to

Pageof 60
Sort By:
Nature Communications|July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLCMaliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Nature Communications|May 13, 2021
Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinomaXin Hu, Junya Fujimoto, Lisha Ying, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2026
Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR ProjectSanja Dacic, Daniel Shenker, Mary Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapyStephen G Swisher, Jack A Roth, Ritsuko Komaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapySanja Dacic, William Travis, Mary Redman, et al.
Nature Communications|October 22, 2016
Genomic heterogeneity of multiple synchronous lung cancerYu Liu, Jianjun Zhang, Lin Li, et al.
Journal for Immunotherapy of Cancer|October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancerNicolas Zhou, Cheuk H Leung, William N William, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 12, 2020
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLCLingzhi Hong, Marcelo V Negrao, Seyedeh S Dibaj, et al.
Nature Communications|July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinomaXin Hu, Junya Fujimoto, Lisha Ying, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Pageof 60

Showing results (571-580 of 594) with videos related to

Sort By:
Pageof 60
Nature Communications|July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLCMaliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Nature Communications|May 13, 2021
Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinomaXin Hu, Junya Fujimoto, Lisha Ying, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2026
Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR ProjectSanja Dacic, Daniel Shenker, Mary Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapyStephen G Swisher, Jack A Roth, Ritsuko Komaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapySanja Dacic, William Travis, Mary Redman, et al.
Nature Communications|October 22, 2016
Genomic heterogeneity of multiple synchronous lung cancerYu Liu, Jianjun Zhang, Lin Li, et al.
Journal for Immunotherapy of Cancer|October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancerNicolas Zhou, Cheuk H Leung, William N William, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 12, 2020
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLCLingzhi Hong, Marcelo V Negrao, Seyedeh S Dibaj, et al.
Nature Communications|July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinomaXin Hu, Junya Fujimoto, Lisha Ying, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Pageof 60